Results 1 to 10 of about 1,800,452 (113)

Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2022
This review continues a series of reviews on the analysis of compounds with cardioprotective properties in a number of biaromatic structures, which include a range of sodium channel blockers. Among voltage-gated sodium channels, the Nav1.5 isoform is the
G. V. Mokrov
doaj   +7 more sources

Pd Nanoparticles Immobilized on Pyridinic N-Rich Carbon Nanosheets for Promoting Suzuki Cross-Coupling Reactions [PDF]

open access: yesNanomaterials
Palladium (Pd) catalysts play a crucial role in facilitating Suzuki cross-coupling reactions for the synthesis of valuable organic compounds. However, conventional heterogeneous Pd catalysts often encounter challenges such as leaching and deactivation ...
Shihao Cui   +7 more
doaj   +3 more sources

Сardioprotective agents with biaromatic structure. Part 2. HCN channel blockers [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2022
Hyperpolarization-activated cyclic nucleotide–gated (HCN) channels, primarily their HCN4 subtype, are one of the promising targets for the development of cardioprotective agents.
G. V. Mokrov
doaj   +4 more sources

Сardioprotective agents with biaromatic structure. Part 6. Beta blockers [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2023
β-Blockers are one of the oldest classes of cardioprotectors used in the treatment of cardiovascular diseases. They reduce the heart rate, have a hypotensive effect, inhibit myocardial contractility and have antiarrhythmic properties.
G. V. Mokrov
doaj   +4 more sources

Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2022
Cardiovascular diseases (CVD) are widespread and the leading cause of morbidity and mortality worldwide. Drugs for the treatment of CVD have been developed since the beginning of the 20th century.
G. V. Mokrov
doaj   +4 more sources

Сardioprotective agents with biaromatic structure. Part 5. Potassium Kv1.5-channels blockers [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2023
The Kv1.5 potassium channel provides an ultra-rapid delayed rectifier potassium current, IKur, that acts selectively in human atrial cells. This makes selective Kv1.5 blockade a promising approach to control atrial arrhythmias without the adverse ...
G. V. Mokrov
doaj   +2 more sources

Сardioprotective agents with biaromatic structure. Part 4. Potassium hERG channels blockers and modulators [PDF]

open access: yesФармакокинетика и Фармакодинамика, 2023
The hERG subtype potassium channel (Kv11.1) is one of the most important and one of the most studied biological targets for the creation of cardioprotective agents.
G. V. Mokrov
doaj   +2 more sources

Recent innovations in crop protection research [PDF]

open access: yesPest Management Science, Volume 81, Issue 5, Page 2406-2418, May 2025.
This review summarizes the latest innovations presented at the 15th IUPAC International Congress on Crop Protection Chemistry in New Delhi in 2023. New products and approaches to control insects, nematodes, diseases, and weeds are discussed, as well as recent advancements in crop enhancement and green pest management research.
Peter Maienfisch, Karsten Koerber
wiley   +2 more sources

Application of Molecular Modeling to Urokinase Inhibitors Development [PDF]

open access: yesBioMed Research International, Volume 2014, Issue 1, 2014., 2014
Urokinase‐type plasminogen activator (uPA) plays an important role in the regulation of diverse physiologic and pathologic processes. Experimental research has shown that elevated uPA expression is associated with cancer progression, metastasis, and shortened survival in patients, whereas suppression of proteolytic activity of uPA leads to evident ...
V. B. Sulimov   +10 more
wiley   +2 more sources

Potential Use of Biaromatic L-Phenylalanyl Derivatives as Therapeutic Agents in the Treatment of Sickle Cell Disease. [PDF]

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1984
M Wilchek, J Altman
exaly   +2 more sources

Home - About - Disclaimer - Privacy